BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Dong-A ST readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of studies Dong-A ST's drugs run\, from Clin
 icalTrials.gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07239440-431@assetmemo.bio
DTSTAMP:20261121T005447Z
DTSTART;VALUE=DATE:20261231
DTEND;VALUE=DATE:20270101
SUMMARY:DA-2811: Phase 2 readout est. (NCT07239440)
DESCRIPTION:DA-2811\, phase 2\, Type 2 Diabetes.\nStudy: Clinical Trial to 
 Evaluate the Efficacy and Safety of DA-2811 When Added to Ongoing BT-1 and
  BT-2 Combination Therapy in Patients With Type 2 Diabetes Who Have Inadeq
 uate Glycemic Control\nEstimated primary completion: December 2026. This i
 s a ClinicalTrials.gov estimate\, not a confirmed readout date\, and it ca
 n move.\nDrug page: https://assetmemo.bio/drug/da-2811#upcoming-events\nRe
 gistry record: https://clinicaltrials.gov/study/NCT07239440
URL:https://assetmemo.bio/drug/da-2811#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
